Claritev (CTEV) director receives 8,977 restricted stock units in grant

Rhea-AI Filing Summary

Prince John Michael reported acquisition or exercise transactions in this Form 4 filing.

Claritev Corp director Prince John Michael received an equity grant of Class A common stock. On April 29, 2026, he was awarded 8,977 restricted stock units at a stated price of $0.00 per share, increasing his directly held position to 21,662 shares.

The restricted stock units vest on the earlier of the one-year anniversary of the grant date or the next regularly scheduled annual meeting of stockholders, subject to continued service. If he voluntarily resigns (other than for cause), the units vest pro rata based on days of service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Prince John Michael

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A common stock	8,977	$0.00	--

Holdings After Transaction: Class A common stock — 21,662 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 8,977 restricted stock units Grant price: $0.00 per share Holdings after grant: 21,662 shares

3 metrics

RSU grant size 8,977 restricted stock units Award of Class A common stock on April 29, 2026

Grant price $0.00 per share Stated price for the restricted stock unit award

Holdings after grant 21,662 shares Total Class A common stock directly held after the transaction

Key Terms

restricted stock units, regularly scheduled annual meeting of stockholders, voluntary resignation, termination for cause

4 terms

restricted stock units financial

"Represents restricted stock units which vest on the earlier of the one-year anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

regularly scheduled annual meeting of stockholders financial

"the date of the next regularly scheduled annual meeting of stockholders of the issuer"

voluntary resignation financial

"in the event of a voluntary resignation other than when grounds for termination for cause exist"

termination for cause financial

"other than when grounds for termination for cause exist"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prince John Michael

(Last) (First) (Middle)

C/O CLARITEV CORPORATION

7900 TYSONS ONE PLACE, SUITE 400

(Street)

MCLEAN VIRGINIA 22102

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Claritev Corp [ CTEV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock	04/29/2026		A(1)		8,977	A	$0	21,662	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units which vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date; provided, however, that the restricted stock units vest pro rata based on the number of days of service provided to the issuer in the event of a voluntary resignation other than when grounds for termination for cause exist.

Remarks:

	/s/ Kent Bartholomew, attorney-in-fact	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Claritev (CTEV) director Prince John Michael report in this Form 4?

Director Prince John Michael reported receiving 8,977 restricted stock units of Claritev Class A common stock. These were granted at a stated price of $0.00 per share and are part of his equity-based compensation as a board member.

How many Claritev (CTEV) shares does Prince John Michael hold after this grant?

After the restricted stock unit grant, Prince John Michael directly holds 21,662 shares of Claritev Class A common stock. This figure reflects his position immediately following the April 29, 2026 equity award reported in the Form 4 filing.

When do the new Claritev (CTEV) restricted stock units vest for Prince John Michael?

The 8,977 restricted stock units vest on the earlier of the one-year anniversary of the April 29, 2026 grant date or the next regularly scheduled annual stockholder meeting. Vesting is conditioned on Prince John Michael’s continued service with Claritev through the applicable vesting date.

What happens to Prince John Michael’s Claritev (CTEV) RSUs if he resigns voluntarily?

If Prince John Michael resigns voluntarily, and his departure is not for cause, the restricted stock units vest on a pro rata basis. The pro rata calculation is based on the number of days of service he provided to Claritev from the grant date through his resignation date.

Was this Claritev (CTEV) Form 4 transaction an open-market purchase or sale?

No, this Form 4 reflects a grant of restricted stock units, not an open-market trade. The transaction code “A” designates a grant, award, or other acquisition, and the reported price per share of $0.00 confirms it was compensation-related, not a market purchase.